Testosterone Completed Phase 4 Trials for Idiopathic Hypogonadotropic Hypogonadism Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01601327Effects of Medications in Patients With Hypogonadism